Facial hypertrichosis induced by Cetuximab, an anti-EGFR monoclonal antibody

Arch Dermatol. 2006 Dec;142(12):1656-7. doi: 10.1001/archderm.142.12.1656.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Carcinoma / drug therapy
  • Carcinoma / secondary
  • Cetuximab
  • ErbB Receptors
  • Face
  • Female
  • Humans
  • Hypertrichosis / chemically induced*
  • Hypertrichosis / pathology
  • Leg
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / pathology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • ErbB Receptors
  • Cetuximab